(Q33913102)

30 July 2017

title

Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study (English)

1 reference

30 July 2017

0 references

1 reference

A Surendiran

1

0 references

author name string

N Balamurugan

2

1 reference

30 July 2017

K Gunaseelan

3

1 reference

30 July 2017

Shahid Akhtar

4

1 reference

30 July 2017

K S Reddy

5

1 reference

30 July 2017

C Adithan

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Indian Journal of Pharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

42

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

40-43

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

30 July 2017

1 reference

Calcium modulation of toxicities due to Cisplatin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Drug-induced hypomagnesaemia : scope and management

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Practical selection of antiemetics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Molecular mechanisms of chemotherapy-induced hair loss.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Focusing on the preventability of adverse drug reactions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Genetic variation in India.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

A method for estimating the probability of adverse drug reactions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Neurologic Complications of Chemotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Treatment for the electrolytic disorders in cancer patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Chemotherapy-and cancer-related nausea and vomiting

29 October 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

29 October 2018

12 December 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Hair loss in cancer chemotherapeutic patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Cisplatin-induced hypokalemic paralysis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Symptomatic hypocalcemia and hypomagnesiemia in cisplatinum-based chemotherapy treated patients: case report.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885639

Refractory potassium repletion due to cisplatin-induced magnesium depletion.

29 October 2018

1 reference

12 December 2020

[Hypocalcemia caused by hypomagnesemia during a treatment with cisplatin]

1 reference

12 December 2020

Preventability and severity assessment in reporting adverse drug reactions

1 reference

12 December 2020

[Investigation of allergic reactions to platinum salts]

1 reference

12 December 2020

Cisplatin nephrotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.4103/0253-7613.62412

1 reference

30 July 2017

1 reference

30 July 2017

1 reference